[Possible problems of lack of objectivity, transparency, duplicate publication and authorship in the cost-effectiveness analysis of celecoxib].
Peiró
S
S
Meneu
R
R
Ortún
V
V
Puig
J
J
D001319:Authorship; D000068579:Celecoxib; D003362:Cost-Benefit Analysis; D015713:Duplicate Publications as Topic; D011643:Publishing / Q000592:standards*; D011720:Pyrazoles; D013449:Sulfonamides / Q000191:economics*
D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib
Posibles problemas de falta de objetividad, transparencia, doble publicación y autoría en el análisis coste-efectividad de celecoxib.